MicroRNA-138 is a prognostic biomarker for triple-negative breast cancer and promotes tumorigenesis via TUSC2 repression

Breast cancer manifests as a spectrum of subtypes with distinct molecular signatures, and different responses to treatment. Of these subtypes, triple-negative breast cancer (TNBC) has the worst prognoses and limited therapeutic options. Here we report aberrant expression of microRNA-138 (miR-138) in...

全面介紹

Saved in:
書目詳細資料
Main Authors: Nama, Srikanth, Muhuri, Manish, Di Pascale, Federica, Quah, Shan, Aswad, Luay, Fullwood, Melissa, Sampath, Prabha
其他作者: School of Biological Sciences
格式: Article
語言:English
出版: 2020
主題:
在線閱讀:https://hdl.handle.net/10356/142966
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍